• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . RSV Disease Burden in Primary Care in Italy: A Multi-Region Pediatric Study, Winter Season 2022-2023

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Apr;18(4):e13282.
doi: 10.1111/irv.13282. RSV Disease Burden in Primary Care in Italy: A Multi-Region Pediatric Study, Winter Season 2022-2023

Michela Scarpaci[SUP] 1 [/SUP], Sara Bracaloni[SUP] 1 [/SUP], Enrica Esposito[SUP] 1 [/SUP], Luigi De Angelis[SUP] 1 [/SUP], Francesco Baglivo[SUP] 1 [/SUP], Beatrice Casini[SUP] 1 [/SUP], Donatella Panatto[SUP] 2 [/SUP], Matilde Ogliastro[SUP] 2 [/SUP], Daniela Loconsole[SUP] 3 [/SUP], Maria Chironna[SUP] 3 [/SUP], Elena Pariani[SUP] 4 [/SUP], Laura Pellegrinelli[SUP] 4 [/SUP], Elisabetta Pandolfi[SUP] 5 [/SUP], Ileana Croci[SUP] 5 [/SUP], Caterina Rizzo[SUP] 1 [/SUP]; RSVComNet Italia



Collaborators, Affiliations
Abstract

Introduction: Human respiratory syncytial virus (RSV) is one of the most frequent causes of respiratory infections in children under 5 years of age, but its socioeconomic impact and burden in primary care settings is still little studied.
Methods: During the 2022/2023 winter season, 55 pediatricians from five Italian regions participated in our community-based study. They collected a nasal swab for RSV molecular test from 650 patients under the age of 5 with acute respiratory infections (ARIs) and performed a baseline questionnaire. The clinical and socioeconomic burden of RSV disease in primary care was evaluated by two follow-up questionnaires completed by the parents of positive children on Days 14 and 30.
Results: RSV laboratory-confirmed cases were 37.8% of the total recruited ARI cases, with RSV subtype B accounting for the majority (65.4%) of RSV-positive swabs. RSV-positive children were younger than RSV-negative ones (median 12.5 vs. 16.5 months). The mean duration of symptoms for all children infected by RSV was 11.47 ± 6.27 days. We did not observe substantial differences in clinical severity between the two RSV subtypes, but RSV-A positive patients required more additional pediatric examinations than RSV-B cases. The socioeconomic impact of RSV infection was considerable, causing 53% of children to be absent from school, 46% of parents to lose working days, and 25% of families to incur extra costs.
Conclusions: Our findings describe a baseline of the RSV disease burden in primary care in Italy before the introduction of upcoming immunization strategies.

Keywords: RSV; acute respiratory infections; primary care; respiratory infection surveillance.

 
Back
Top Bottom